nileshjain...nileshjain theboardof directors makerslaboratories limited 54-d,kandivliindustrial...
TRANSCRIPT
Nilesh Jain
The Board of DirectorsMakers Laboratories Limited54-D, Kandivli Industrial EstateKandivli (W)Mumbai 400 067
Dear Sir,
E-5-10, Jai Taramani C.H.S,Bangur Nagar, Goregaon (W).Mumbai - 104
June 1, 2020
I shall be retiring as a Director at the ensuing Annual General, Meeting ofthe Company.
I hereby give my consent to continue to act as a Director of the Company,ifre-appointed.
Thanking you
Yours faithfully
• J It ~-.:J~~~ -,/ Nilesh Jain
AGREEMENT FOR APPOINTMENT OF WHOLETIME DIRECTOR
~ MAHA~SHTRA
B
Ig
Ig
() 2019 () fit 789047um~ Gf)F'-lfC1'4, '1~tr.~.fcr.Qj. (, 000 t) 0 ~
,;,4 FEB 2020.a~3if~ ~
AG~EEMENT made at Mumbai this 15th day. of June, 2020 BETWEEN Makers
Latiratories Limited a Company incorporated under the Companies Act, 1956 and,having its Registered office at 54-0, Kandivli Industrial Estate, Kandivli (West), Mumbai
40~067 (hereinafter referred to as "the Company" which expression shall, unless there
is anything repugnant in the subject or context mean and include its successors and
ass~ns) of the One Part
AND
2
WHEREAS Mr. Saahil Parikh was re-appointed as the Wholetime Director of the
Company for a period of 3 years with effect from 11th August, 2020 at the Meeting of
the Board of Directors of the Company held on 15th June, 2020 subject to compliance
with Sections 196, 197, 203 and Schedule V and other applicable provisions, if any,
of the Companies Act, 2013 and also subject to the approval of the Shareholders.
NOW IT IS HEREBY AGREED BY AND BETWEEN THE PARTIES HERETO AS
FOllOWS:
1. Mr. Saahil Parikh is hereby re-appointed as Wholetime Director of the Company, for
a period of 3 (three) years with effect from 11th August, 2020 subject to the
appointment being previously determined in pursuance of any of the provisions of
this Agreement.
2. The Wholetime Director shall exercise and perform such powers and duties as the
Board shall from time to time, determine, and subject to any directions and
restrictions, from time to time, given and imposed by the Board and perform all other
acts, deeds and things which, in the ordinary course of business, he may consider
necessary or proper in the interest of the Company.
3. The Wholetime Director shall devote his whole-time attention and abilities to the
business of the Company and shall obey the orders, from time to time, of the Board
and in all respects confirm to and comply with the directions and regulations made
by the Board, and shall use his best endeavors to promote interests of the
Company.
4. During the period of his employment the Wholetime Director shall whenever required
by the Company undertake such travelling in India and elsewhere as the Board may
from time to time direct in connection with or in relation to the business of the
Company.
5. The Company shall, in consideration of the performance of his duties, pay to the
Wholetime Director during the continuance of this Agreement, the following
remuneration:
a. Salary of RS.2,60,0001- (Rupees Two lacs Sixty Thousand Only) per month with
such increments as may be decided by the Board subject to a ceiling of
Rs. 3,30,0001- (Rupees Three lacs Thirty Thousand Only) per month.
3
b. Commission: Such remuneration by way of commission, in addition to the above
salary and perquisites, calculated with reference to the net profits of the
Company in a particular financial year and as may be determined by the Board of
Directors of the Company, subject to the overall ceilings stipulated Sections 197
and other applicable provisions of the Companies Act, 2013.
The specific amount payable to the Wholetime Director will be based on certain
performance criteria to be laid down by the Board and will be payable annually
after annual accounts have been adopted by the shareholders.
c. Perquisites: In addition to the salary and commission the Wholetime Director
shall be entitled to the following perquisites:
i. Housing: The expenditure incurred by the Company on hiring furnished
accommodation for the Wholetime Director will be subject to a maximum of
thirty per cent of the Salary. In case no accommodation is provided by the
Company, the Wholetime Director shall be entitled to the house rent
allowance subject to the said ceiling of 30% of the salary.
Explanation: The expenditure incurred by the Company on gas, electricity,
water and furnishings shall be valued as per the Income-Tax Rules, 1962.
This shall, however, be subject to a ceiling of ten per cent of the salary of the
Wholetime Director.
ii. Medical, Hospitalization and Health-care expenses Reimbursement:
Expenses incurred for the Wholetime Director and his family to be paid in
accordance with any rules specified by the Company subject to a ceiling of
Rs. 35,0001- per annum.
iii. Leave Travel Concession: For the Wholetime Director and his family, once in
a year incurred in accordance with any rules specified by the Company
subject to a ceiling of 1 month salary.
iv. Personal accident insurance: As per the Rules specified by the Company.
v. Provident Fund: Company's contribution to Provident Fund shall be as per the
scheme applicable to the employees of the Company.
l
6.
7.
4
vi. Contribution to National Pension Scheme: Company's contribution to any
superannuation fund or national pension scheme shall be in accordance with
the rules of the scheme as may be applicable or as may be framed / decided
by the Company.
Contribution to provident fund I superannuation fund and national pension
scheme will not be included in the computation of perquisites to the extent
these either singly or put together are not taxable under the Income-tax Act.
vii. Gratuity: As per the rules of the Company, payable in accordance with the
Approved Gratuity Fund and which shall not exceed half a month's salary for
each completed year of service.
Contribution to provident fund and gratuity will not be included in the
computation of perquisites.
viii. Encashment of Leave: Encashment of Leave at the end of the tenure of the
Wholetime Director will not be included in the computation of perquisites.
ix. Car: Provision of car for use on Company's business is not to be considered
as perquisites.
x. Telephone: Telephone(s) at the residence of the Wholetime Director and
mobile phone(s) for official use is not to be considered as perquisites.
In the event of no profit or inadequacy of profits, the Company shall pay the
aforesaid remuneration to the Wholetime Director by way of salary and
perquisites as minimum remuneration.
The Wholetime Director shall be entitled to annual privilege leave on full salary
for a period of thirty days and such leave shall be allowed to be accumulated for
not more than ninety days . 's tenure of appointment.OltA 0
,,?:~r-'/.~r gUMBA1'r
I .~:
'.
5
8. The Wholetime Director shall be entitled to :
a) the reimbursement of entertainment expenses actually and properly incurred
by him in the course of the legitimate business of the Company in
accordance with the rules and regulations of the Company in force from time
to time or as may be approved by the Board of Directors; and
b) the reimbursement of travelling, hotel and other expenses incurred by him in
India and abroad exclusively on the business of the Company in accordance
with the rules and regulations of the Company in force from time to time or as
approved by the Board of Directors.
9. The Wholetime Director shall devote his whole-time attention and abilities to the
business of the Company and shall obey the orders, from time to time, of the
Board and in all respects confirm to and comply with the directions and
regulations made by the Board, and shall use his best endeavors to promote
interests of the Company.
10. As long as Mr. Saahil Parikh functions as the Wholetime Director, he shall not be
paid any sitting fee for attending the Meetings of the Board of Directors or
Committee thereof.
11. As long as Mr. Saahil Parikh functions as Wholetime Director, he shall not
become interested or otherwise concerned directly or through his wife and/or
children, in any selling agency of the Company except with the consent of the
Company accorded by a special resolution and the approval of the Central
Government.
12. The Wholetime Director shall not during the continuance of his employment with
the Company or at any time thereafter divulge or disclose to any person
whomsoever or to make any use whatsoever for his own purpose or for any
purpose other than that of the Company or any information or knowledge
obtained by him during his employment as to the business or affairs of the
Company or its methods or as to any trade secrets, or secret processes of the
Company and the Wholetime Director shall during the continuance of his
employment hereun r also use his best endeavor to prevent any other person
'.
13.
14.
15.
16.
17.
6
from so doing provided however that such divulgence or disclosure by the
Wholetime Director to officers and employees of the Company for the purpose of
business of the Company shall not be deemed to be contravention of this clause.
Any property of the company or relating to the business of the Company,
including memoranda, notes, records, reports, plates, sketches, plans, recorded
diskettes, drives, tapes, electronic memory gadgets or other documents which
may be in the possession of or under the control of the Wholetime Director or to
which the Wholetime Director has, at any time access shall, at the time of the
termination of his employment be delivered by the Wholetime Director to the
Company or as it shall direct and the Wholetime Director shall not be entitled to
the copyright in any such document which he hereby acknowledges to be vested,in the Company or its assigns and binds himself not to retain copies of any of
them.
If the Wholetime Director shall at any time be prevented by ill health or accident
or any physical or mental disability from performing his duties hereunder, he shall
inform the Company and supply it with such details as it may reasonably require
and if he shall be unable by reasons of ill health or accident or disability for a
period of 90 days in any period of twelve consecutive calendar months, to
perform his duties hereunder the Company may forthwith terminate his
employment.
The Company shall be entitled to forthwith terminate the agreement if he
becomes insolvent or makes any composition or arrangement with his creditors
or he ceases to be a Director of the Company.
In case of death of the Wholetime Director in the course of his employment with
the Company, the Company shall pay to his legal representati~es the salary and
other emoluments payable hereunder for the then current mbnth together with
any such further sum as the Board in its sole and uncontrolled discretion may
determine.
If the Wholetime Director is guilty of inattention to or negligence in the conduct of
the business or of any other act or omission inconsistent with his duties as
Wholetime t Fir. any breach of this Agreement which in the opinion of,p --::.1~
~
l
..7
the Board renders his retirement from the office of Wholetime Director desirable,
the Company by not less than thirty days notice in writing to the Wholetime
Director determine this Agreement and upon the expiration of such notice the
Wholetime Director shall cease to be the Director of the Company.
18. Notwithstanding anything to the contrary contained in the Agreement, either party
shall be entitled to terminate the Agreement, at anytime by giving to the other
party 60 days notice in writing in that behalf without the necessity of showing any
cause and on the expiry of the period of such notice this Agreement shall stand
determined and the Wholetime Director shall cease to be the Director of the
Company. Provided that the aforesaid notice may, be waived mutually by the
parties hereto.
19. The terms and conditions including the remuneration payable to the Wholetime
Director of the said appointment and/or Agreement may be altered and varied
from time to time by the Board as it may, in its discretion, deem fit.
20. This Agreement represents the entire agreement, between the parties hereto on
the subject matter thereof.
IN WITNESS WHEREOF the parties hereto have set their hands on the day, month and
year hereinabove mentioned.
The Common Seal of Makers Laboratories Limited has
been affixed hereunto in the presence of Mr. Nilesh
Jain, Wholetime Director who has been duly authorised
for the purpose by a Resolution of Board of Directors of
the Company passed at the Meeting held on 15th June,
2020
SIGNED AND DELIVERED by the said Mr. Saahil
Parikh in the presence of
For Makers Laboratorie5]~~~~
~Ole Time Director
KALE & ASSOCIATESCost Accountants703, Kaka Sohni Marg, Off: Gadkari Marg, Thane (West), PIN - 400602Tel: 022-25368627 Mobile: 9892849029 email: [email protected]
Date: 26-04-2020ToThe Board of DirectorsMakers Laboratories Ltd.54-0, Kandivli co-op. Industrial EstateKandivli(West), Mumbai - 400067.
Sub: Proposed appointment as Cost Auditors, for the Financial Year commencing 1.4.2020Re: Certificate w.rt compliances under Section 139 read with section 148 of the Companies Act,
2013Re: Certificate w.rt arms length relationship
Dear Sir,
With reference to the proposal for re-appointment as Cost Auditors of Maker Laboratories Ltd. ("theCompany") for the financial year commencing 1st April, 2020, please consider this certificate as ourconsent, in terms of the requirements of section 139 of the Companies Act, 2013 ("the Act"), to act assuch Cost Auditors if so appointed by the Board of Directors of the Company.
We would like to inform you that we do not suffer from any disqualifications as specified,inter alia, under the provisions of section 141 of the Act, read with sections 139 and 148of the Act. We further confirm that the appointment, if made, will be within the limitsprescribed under the provisions of section 141(3)(g) read with section 148 of the Act.We would also like to inform you that the sole proprietor of the firm holds the Certificateof Practice issued by the Institute of Cost Accountants of India and is in whole timepractice. Our Permanent Account Number is AAOPP8816H.
We further certify that we are an independent firm of Cost Accountants and are at arm'slength relationship with the Company, and further confirm that there are no orders orproceedings which are pending against our firm or the sole proprietor, relating toprofessional matters of conduct, before the Institute of Cost Accountants of India or anycompetent authority or any court.
Thanking you,
Yours truly,
Sampada KaleProprietor - Cost AccountantMembership No.: M/17869Firm Registration No.: 001819
Register of Directors and Key Managerial Personnel and their Shareholding
[Pursuant to section 88 (1)(a) of the Companies Act, 2013 and rule 3(1) of the Companies (Management and Administration) Rules, 2014]
Name of the company: Makers Laboratories Limited
Registered office address: 54D, Kandivli Industrial Estate, Kandivli (W), Mumbai - 400067
(TO BE MAINTAINED SEPARATELY FOR EACH DIRECTOR AND KMP)
(1) (4) (5) (6) (7) (8) (9) (9) (11) (12) (13) (14) (15)
1
2
3
4
5
Office of director or KMP held or relinquished in any other body corporate :
Sr. No. Date of Appointment
1
2 20/11/2019EVSE READY INDIA PRIVATE
LIMITED
Name of the CompanySecurities have been
pledged or any
encumbrance has been
Date of
disposal
Price
received
on
Other
considerat
ion
Cumulativ
e balance
and
Mode of
acquisition
of
Mode of holding
– physical or
dematerialized (2)
KREBS BIOCHEMICALS AND
INDUSTRIES LIMITED 12/02/2016
Other consideration paid
for acquisitionS. No.
Number of
Securities
Descriptio
n of
Securities
Nominal
Value of
Securities
Date of
Acquisition
Price paid
for
acquisition (16)
Name of the Company Date of Cessation
Date of birth : 22.03.1949 Membership number of the ICSI in case of Company Secretary, if applicable: N.A.
Permanent Account Number (mandatory for KMP if not having DIN) : ABHPV6666R
Residential address:
Present: Flat No. 1902, Challenger Tower-2, Thakur Village, Kandivali (E), Mumbai- 400101, Maharashtra, India. Permanent: Same as Present
Father's Name : Mr. Kamal Kishore Prasad Verma
Date of appointment and reappointment in the company : Appointment - 13.02.2019
Regularisation: 08.08.2019
Mother's Name : Late. Lal Mani Verma Date of cessation of office and reasons therefor :
Spouse's Name (If married) : Mrs. Nilam Verma Office of director or KMP held or relinquished in any other body corporate : N.A
Director Identification Number (optional for key managerial personnel) : '02166789 Nationality (including the nationality of origin, if different) : Indian
Present name and surname in full : Mr. Raj Kamal Prasad Verma Occupation : Service
Any former name or surname in full : N.A. Date of the board resolution in which the appointment was made : 13.02.2019
Register of Directors and Key Managerial Personnel and their Shareholding
[Pursuant to section 88 (1)(a) of the Companies Act, 2013 and rule 3(1) of the Companies (Management and Administration) Rules, 2014]
Name of the company: Makers Laboratories Limited
Registered office address: 54D, Kandivli Industrial Estate, Kandivli (W), Mumbai - 400067
(TO BE MAINTAINED SEPARATELY FOR EACH DIRECTOR AND KMP)
(1) (4) (5) (6) (7) (8) (9) (9) (11) (12) (13) (14) (15)
1
2
3
4
5
Office of director or KMP held or relinquished in any other body corporate :
Sr. No. Date of Appointment
1
2
3
Name of the CompanySecurities have been
pledged or any
encumbrance has been
SAM TAX AND FINANCE
SERVICES PRIVATE LIMITED
AVIK PHARMACEUTICAL
LIMITED
24/12/2002
17/09/2014
Date of
disposal
Price
received
on
Other
considerat
ion
Cumulativ
e balance
and
Mode of
acquisition
of
Mode of holding
– physical or
dematerialized
RAVI KUMAR DISTILLERIES
LIMITED
03/11/2010
Other consideration paid
for acquisition
(2)
S. No.Number of
Securities
Descriptio
n of
Securities
Nominal
Value of
Securities
Date of
Acquisition
Price paid
for
acquisition (16)
Name of the Company Date of Cessation
Date of birth : 21.06.1953 Membership number of the ICSI in case of Company Secretary, if applicable: N.A.
Permanent Account Number (mandatory for KMP if not having DIN) : AAEPK4407B
Residential address:
Present: 601, 6th Floor, Rustomjee Ozone CHS Ltd. Tower NO.6, Link Road, Goregaon (West), Mumbai - 400 104, Maharashtra, India. Permanent: Same as Present
Father's Name : Mr. Mukanchand Kathariya
Date of appointment and reappointment in the company : Appointment - 13.02.2019
Regularisation: 08.08.2019
Mother's Name : Mrs. Khamabai Kathariya Date of cessation of office and reasons therefor :
Spouse's Name (If married) : Mrs. Asha Kathariya Office of director or KMP held or relinquished in any other body corporate : N.A
Director Identification Number (optional for key managerial personnel) : '00281395 Nationality (including the nationality of origin, if different) : Indian
Present name and surname in full : Mr. Popatlal Mukanchand Kathariya Occupation : Service
Any former name or surname in full : N.A. Date of the board resolution in which the appointment was made : 13.02.2019
Register of Directors and Key Managerial Personnel and their Shareholding
[Pursuant to section 88 (1)(a) of the Companies Act, 2013 and rule 3(1) of the Companies (Management and Administration) Rules, 2014]
Name of the company: Makers Laboratories Limited
Registered office address: 54D, Kandivli Industrial Estate, Kandivli (W), Mumbai - 400067
(TO BE MAINTAINED SEPARATELY FOR EACH DIRECTOR AND KMP)
Details of securities held in the Company, its holding company, subsidiaries, subsidiaries of the company’s holding company and associate companies:
(1) (4) (5) (6) (7) (8) (9) (9) (11) (12) (13) (14) (15)
Office of director or KMP held or relinquished in any other body corporate :
Sr. No.
Mode of
holding –
physical or
dematerialized
form
Name of the Company
Securities have been
pledged or any
encumbrance has
been created
Other
consideration
paid for
acquisition
Date of
disposal
Price
received
on
disposal
Other
considerat
ion
received
on
disposal
Cumulativ
e balance
and
number of
securities
held after
each
Mode of
acquisitio
n of
securities
S. No.Number of
Securities
Descriptio
n of
Securities
Nominal
Value of
Securities
Date of
Acquisitio
n
Price paid
for
acquisitio
n of
securities
Name of the Company Date of Appointment Date of Cessation
-
(2) (16)
Date of birth : 24.06.1973 Membership number of the ICSI in case of Company Secretary, if applicable: N.A.
Permanent Account Number (mandatory for KMP if not having DIN) : N.A.
Residential address:
Present: Jai Bhagwan Building, 3rd Floor, Flat no. 10, 87, Walkeshwar Road, Near White House Mallabar Hills, Mumbai
400006, Maharashtra, India
Permanent: Same as Present
Father's Name : Mr. Chinubhai Dahyalal Shah
Date of appointment and reappointment in the company : Appointment - 29/01/2018
Regularisation : 02/08/2018
Mother's Name : Mrs. Kanchanben Shah Date of cessation of office and reasons therefor :
Spouse's Name (If married) : - Office of director or KMP held or relinquished in any other body corporate :
Director Identification Number (optional for key managerial personnel) : 07995542 Nationality (including the nationality of origin, if different) : Indian
Present name and surname in full : Ms. Dipti Chinubhai Shah Occupation : Lawyer
Any former name or surname in full : N.A. Date of the board resolution in which the appointment was made : 29/01/2018
Register of Directors and Key Managerial Personnel and their Shareholding
[Pursuant to section 88 (1)(a) of the Companies Act, 2013 and rule 3(1) of the Companies (Management and Administration) Rules, 2014]
Name of the company: Makers Laboratories Limited
Registered office address: 54D, Kandivli Industrial Estate, Kandivli (W), Mumbai - 400067
(TO BE MAINTAINED SEPARATELY FOR EACH DIRECTOR AND KMP)
(1) (4) (5) (6) (7) (8) (9) (9) (11) (12) (13) (14) (15)
1
2
3
4
5
Office of director or KMP held or relinquished in any other body corporate :
Sr. No. Date of Appointment
Name of the CompanySecurities have been
pledged or any
encumbrance has been
Date of
disposal
Price
received
on
Other
considerat
ion
Cumulativ
e balance
and
Mode of
acquisition
of
Mode of holding
– physical or
dematerialized (2)
-
S. No.Number of
Securities
Descriptio
n of
Securities
Nominal
Value of
Securities
Date of
Acquisition
Price paid
for
acquisition
Other consideration paid
for acquisition
(16)
Name of the Company Date of Cessation
Date of birth : 28.04.1975 Membership number of the ICSI in case of Company Secretary, if applicable: N.A.
Permanent Account Number (mandatory for KMP if not having DIN) : AACPJ1539R
Residential address:
Present: E-5-10, Jai Taramani C.H.S, Bangur Nagar, Goregaon (W). Mumbai- 104, Maharashtra, India. Permanent: Same as Present
Father's Name : Mr. Shivraj Anchalya
Date of appointment and reappointment in the company : Appointment - 13.02.2019
Regularisation: 08.08.2019
Mother's Name : Mrs. Chanda Anchalya Date of cessation of office and reasons therefor :
Spouse's Name (If married) : Mrs. Pooja Jain Office of director or KMP held or relinquished in any other body corporate : N.A
Director Identification Number (optional for key managerial personnel) : '05263110 Nationality (including the nationality of origin, if different) : Indian
Present name and surname in full : Mr. Nilesh Jain Occupation : Service
Any former name or surname in full : N.A. Date of the board resolution in which the appointment was made : 13.02.2019
Register of Directors and Key Managerial Personnel and their Shareholding
[Pursuant to section 88 (1)(a) of the Companies Act, 2013 and rule 3(1) of the Companies (Management and Administration) Rules, 2014]
Name of the company: Makers Laboratories Limited
Registered office address: 54D, Kandivli Industrial Estate, Kandivli (W), Mumbai - 400067
(TO BE MAINTAINED SEPARATELY FOR EACH DIRECTOR AND KMP)
Details of securities held in the Company, its holding company, subsidiaries, subsidiaries of the company’s holding company and associate companies:
(1) (4) (5) (6) (7) (8) (9) (9) (11) (12) (13) (14) (15)
1 660 Equity Rs. 10/- 660 Physical
2 12000 Equity Rs. 10/- 08.06.2018 12660
Secondary
Market
purchase
Demat
(IN300484131
40087)
3 4182 Equity Rs. 10/- 21.09.2018 16842
Secondary
Market
purchase
Demat
(IN300484131
40087)
Office of director or KMP held or relinquished in any other body corporate :
Sr. No.
Mode of
holding –
physical or
dematerialized
form
Name of the Company
Securities have been
pledged or any
encumbrance has
been created
Other
consideration
paid for
acquisition
Date of
disposal
Price
received
on
disposal
Other
considerat
ion
received
on
disposal
Cumulativ
e balance
and
number of
securities
held after
each
Mode of
acquisitio
n of
securities
S. No.Number of
Securities
Descriptio
n of
Securities
Nominal
Value of
Securities
Date of
Acquisition
Price paid
for
acquisitio
n of
securities
Name of the Company Date of Appointment Date of Cessation
-
(2) (16)
no
no
no
Makers Laboratories
Limited
Date of birth : 27.01.1975 Membership number of the ICSI in case of Company Secretary, if applicable: N.A.
Permanent Account Number (mandatory for KMP if not having DIN) : N.A.
Residential address:
Present: 3, Shailraj Bunglows, B/H Rajsuya Bunglows, Ramdevnagar, Satellite, Ahmedabad, 380015, Gujrat, India Permenent: Same as Present
Father's Name : Mr. Umesh Shantilal Parikh
Date of appointment and reappointment in the company : Appointment - 11.08.2011 ; Re-
appointment: 11.08.2017
Mother's Name : Mrs. Dhanishtha Parikh Date of cessation of office and reasons therefor :
Spouse's Name (If married) : Mrs. Radhika Parikh Office of director or KMP held or relinquished in any other body corporate :
Director Identification Number (optional for key managerial personnel) : 00400079 Nationality (including the nationality of origin, if different) : Indian
Present name and surname in full : Mr. Saahil Umesh Parikh Occupation : Service
Any former name or surname in full : N.A. Date of the board resolution in which the appointment was made :
Register of Directors and Key Managerial Personnel and their Shareholding
[Pursuant to section 88 (1)(a) of the Companies Act, 2013 and rule 3(1) of the Companies (Management and Administration) Rules, 2014]
Name of the company: Makers Laboratories Limited
Registered office address: 54D, Kandivli Industrial Estate, Kandivli (W), Mumbai - 400067
(TO BE MAINTAINED SEPARATELY FOR EACH DIRECTOR AND KMP)
Details of securities held in the Company, its holding company, subsidiaries, subsidiaries of the company’s holding company and associate companies:
(1) (4) (5) (6) (7) (8) (9) (9) (11) (12) (13) (14) (15)
1 660 Equity Rs. 10/- Physical
2 12000 Equity Rs. 10/- 08.06.2018 12660
Secondary
Market
purchase
Demat
(IN300484131
40087)
3 4182 Equity Rs. 10/- 21.09.2018 16842
Secondary
Market
purchase
Demat
(IN300484131
40087)
Office of director or KMP held or relinquished in any other body corporate :
Sr. No.
Mode of
holding –
physical or
dematerialized
form
Name of the Company
Securities have been
pledged or any
encumbrance has
been created
Other consideration
paid for acquisition
Date of
disposal
Price
received
on
disposal
Other
consideration
received on
disposal
Cumulative
balance and
number of
securities
held after
each
transaction
Mode of
acquisition
of securities
S. No.Number of
Securities
Description
of
Securities
Nominal
Value of
Securities
Date of
Acquisition
Price paid
for
acquisition
of securities
Name of the Company Date of Appointment Date of Cessation
-
(2) (16)
no
no
no
Makers Laboratories
Limited
Date of birth : 27.01.1975 Membership number of the ICSI in case of Company Secretary, if applicable: N.A.
Permanent Account Number (mandatory for KMP if not having DIN) : AGWPP5355R
Residential address:
Present: 3, Shailraj Bunglows, B/H Rajsuya Bunglows, Ramdevnagar, Satellite, Ahmedabad, 380015, Gujrat, India Permenent: Same as Present
Father's Name : Mr. Umesh Shantilal Parikh Date of appointment and reappointment in the company : Appointment - 30.10.2017
Mother's Name : Mrs. Dhanishtha Parikh Date of cessation of office and reasons therefor :
Spouse's Name (If married) : Mrs. Radhika Parikh Office of director or KMP held or relinquished in any other body corporate :
Director Identification Number (optional for key managerial personnel) : Nationality (including the nationality of origin, if different) : Indian
Present name and surname in full : Mr. Saahil Umesh Parikh Occupation : Service
Any former name or surname in full : N.A. Date of the board resolution in which the appointment was made : 27.10.2017
Register of Directors and Key Managerial Personnel and their Shareholding
[Pursuant to section 88 (1)(a) of the Companies Act, 2013 and rule 3(1) of the Companies (Management and Administration) Rules, 2014]
Name of the company: Makers Laboratories Limited
Registered office address: 54D, Kandivli Industrial Estate, Kandivli (W), Mumbai - 400067
(TO BE MAINTAINED SEPARATELY FOR EACH DIRECTOR AND KMP)
Details of securities held in the Company, its holding company, subsidiaries, subsidiaries of the company’s holding company and associate companies:
(1) (4) (5) (6) (7) (8) (9) (9) (11) (12) (13) (14) (15)
400 Equity 10 400
Rights Issue
in 1999-
2000
Demat
Office of director or KMP held or relinquished in any other body corporate :
Sr. No.
Mode of
holding –
physical or
dematerialized
form
Name of the Company
Securities have been
pledged or any
encumbrance has
been created
Other consideration
paid for acquisition
Date of
disposal
Price
received
on
disposal
Other
consideration
received on
disposal
Cumulative
balance and
number of
securities
held after
each
transaction
Mode of
acquisition
of securities
S. No.Number of
Securities
Description
of
Securities
Nominal
Value of
Securities
Date of
Acquisition
Price paid
for
acquisition
of securities
Name of the Company Date of Appointment Date of Cessation
-
(2) (16)
Makers Laboratories
LimitedNo
Date of birth : 08.03.1967 Membership number of the ICSI in case of Company Secretary, if applicable: N.A.
Permanent Account Number (mandatory for KMP if not having DIN) : AJHPK9366K
Residential address:
Present: A/11-4, Dahivali CHS, L.M. Road, Kandarpada, Dahisar West, Mumbai - 400068 Maharashtra, India Permanent: Same as Present
Father's Name : Mr. Nagesh Krishnaji Kadam Date of appointment and reappointment in the company : Appointment - 30.10.2017
Mother's Name : Date of cessation of office and reasons therefor : NA
Spouse's Name (If married) : Office of director or KMP held or relinquished in any other body corporate :
Director Identification Number (optional for key managerial personnel) : Nationality (including the nationality of origin, if different) : Indian
Present name and surname in full : Mr. Sandeep Nagesh Kadam Occupation : Service
Any former name or surname in full : N.A. Date of the board resolution in which the appointment was made :
Register of Directors and Key Managerial Personnel and their Shareholding
[Pursuant to section 88 (1)(a) of the Companies Act, 2013 and rule 3(1) of the Companies (Management and Administration) Rules, 2014]
Name of the company: Makers Laboratories Limited
Registered office address: 54D, Kandivli Industrial Estate, Kandivli (W), Mumbai - 400067
(TO BE MAINTAINED SEPARATELY FOR EACH DIRECTOR AND KMP)
Details of securities held in the Company, its holding company, subsidiaries, subsidiaries of the company’s holding company and associate companies:
(1) (4) (5) (6) (7) (8) (9) (9) (11) (12) (13) (14) (15)
Office of director or KMP held or relinquished in any other body corporate :
Sr. No.
Mode of
holding –
physical or
dematerialized
form
Name of the Company
Securities have been
pledged or any
encumbrance has been
created
Other consideration paid
for acquisition
Date of
disposal
Price
received
on
disposal
Other
considerat
ion
received
on
disposal
Cumulativ
e balance
and
number of
securities
held after
each
Mode of
acquisitio
n of
securities
S. No.Number of
Securities
Descriptio
n of
Securities
Nominal
Value of
Securities
Date of
Acquisitio
n
Price paid
for
acquisitio
n of
securities
Name of the Company Date of Appointment Date of Cessation
-
(2) (16)
Date of birth : 24.10.1982 Membership number of the ICSI in case of Company Secretary, if applicable: ACS21844
Permanent Account Number (mandatory for KMP if not having DIN) : AOVPM3715M
Residential address:
Present: 2A/G2, Green Meadows, Lokhandwala, Kandivali (E), Mumbai, 400101, Maharashtra, India Permanent: Same as Present
Father's Name : Mr. Vinod Vasantlal Mashru Date of appointment and reappointment in the company : Appointment - 09.08.2016
Mother's Name : Mrs. Vilasben V Mashru Date of cessation of office and reasons therefor :
Spouse's Name (If married) : Mr. Hemang K Danani Office of director or KMP held or relinquished in any other body corporate :
Director Identification Number (optional for key managerial personnel) : Nationality (including the nationality of origin, if different) : Indian
Present name and surname in full : Ms. Khyati Danani Occupation : Service
Any former name or surname in full : N.A. Date of the board resolution in which the appointment was made : 09.08.2016
Sr. No.
Charge ID Date of creation of chargeor date of acquisition ofproperty subject to charge
Date of registrationof creation ofcharge
Short descriptionof the propertycharged
Period and amountsecured by thecharge
Names and addresses ofthe charge holder
Particulars of the termsand conditions of thecharge
Description of theinstrument creatingthe charge
Date of modification ofcharge
Date of registration ofmodification of charge
Description of theinstrument modifying thecharge
Particularsofmodification
Date ofsatisfaction
Date of registration ofsatisfaction
Facts and date ofcondonation of delay, if any
Reasons for delay infiling for registration ofcreation, modification orsatisfaction of the charge,if any
(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17)1 100210705 25/09/2018 24/10/2018 Exclusive Charge on
plant and machinery located at new ophthalmic products manufacturing facility at Naroda, Ahmedabad. More particularly described in schedule II to DOH
60 months and Rs. 87,000,000 (Rupees Eight Crore Seventy Lacs only)
YES BANK LIMITED Nehru Centre, 9th Floor, Discovery of India Dr. A.B. Road,Worli, Mumbai 400 018
The facility will be covered by exclusive Charge on plant and machinery located at new ophthalmic products manufacturing facility at Naroda, Ahmedabad. More particularly described in schedule II to DOH
Deed of Hypothecation dated 25/09/2018
NA NA NA NA NA NA NA NA
2 100279254 10/07/2019 05/08/2019 Immovable property as more particularly described in schedule II to MoE
60 months and Rs. 87,000,000 (Rupees Eight Crore Seventy Lacs only)
YES BANK LIMITED Nehru Centre, 9th Floor, Discovery of India Dr. A.B. Road,Worli, Mumbai 400 018
The facility will be covered by exclusive Charge on immovable property as more particularly described in schedule II to MoE
Memorandum of Equitable Mortgage by Deposit of Title Deeds dated 10/07/2019
NA NA NA NA NA NA NA NA
MAKERS LABORATORIES LIMITED
REGISTER OF CHARGES[Pursuant to Section 85 sub rule (1) of the rule 10 of the Companies (Registration of Charges) Rules, 2014]
A. Contracts or agreements with any Related Party under section 188 or in which any Director is concerned or interested under sub - section (2) of section 184
No. of
Directors
present in
the
meeting
Directors
voting in
favour
Directors
voting
against
Directors
remaining
neutral
(1) (2) (3) (4) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17)
01.04.2019 Yes 08.08.2019
to Inv Date Amt
30.06.2019 431SP90001 05/04/2019 1,543,726
431SP90002 06/04/2019 1,360,350
431SP90003 10/04/2019 943,343
431SP90004 11/04/2019 570,018
431SP90005 12/04/2019 993,398
431SP90006 15/04/2019 674,542
431SP90007 17/04/2019 1,095,938
431SP90008 22/04/2019 1,105,406
431SP90009 26/04/2019 1,112,004
431SP90010 01/05/2019 149,860
431SP90011 01/05/2019 1,115,648
431SP90012 04/05/2019 179,832
431SP90013 04/05/2019 358,750
431SP90014 10/05/2019 1,209,895
431SP90015 12/05/2019 756,110
431SP90016 17/05/2019 503,451
431SP90017 23/05/2019 1,003,690
431SP90018 26/05/2019 1,153,810
431SP90019 31/05/2019 1,071,434
431SP90020 03/06/2019 1,247,330
431SP90021 08/06/2019 149,863
431SP90022 08/06/2019 1,400,321
431SP90023 12/06/2019 959,903
431SP90024 13/06/2019 546,123
431SP90025 17/06/2019 922,549
431SP90026 20/06/2019 513,151
431SP90027 22/06/2019 399,068
431SP90028 24/06/2019 959,156
431SP90029 26/06/2019 1,175,833
431SP90030 27/06/2019 610,728
431SP90031 29/06/2019 993,704
08.08.2019
Inv Date Amt
431LS90001 19/04/2019 195,485
431LS90002 04/05/2019 684,762
431LS90003 06/05/2019 343,465
431LS90004 24/05/2019 534,803
431LS90005 26/05/2019 378,336
431LS90006 31/05/2019 314,664
431LS90007 27/05/2019 437,318
431LS90008 27/05/2019 179,142
431LS90010 07/06/2019 580,442
431LS90011 24/06/2019 165,312
01.04.2019 08.08.2019
Signature Remarks,if
any
Date of the
next
meeting at
which
register was
placed for
signature
Date of
Contract /
Arrangement
Name of the
party with
which
contract is
entered into
Principal terms and conditions Date of
shareholders
approval if
any
Reference
of specific
items - (a)
to (g)
under sub-
section (1)
of section
188
Amount
of
contract
or
arrangem
ent
Ipca
Laboratories
Limited
Ipca
Whether the
transaction
is at arm's
length basis
Details of Manufacturing Charges
Details of Sales
Details of Sales
Date of
approval
at the
meeting of
the Board
MAKERS LABORATORIES LIMITED
Form MBP - 4
Register of Contracts with Related Party and Contracts and Bodies etc. in which Directors are interested
[Pursuant to section 189(1) and Rule 16(1)]
Details of voting on such resolution
(5)
Name of
the
Interested
Director
Relation
with
Director /
Company /
Nature of
concern or
Interest
A. Contracts or agreements with any Related Party under section 188 or in which any Director is concerned or interested under sub - section (2) of section 184
No. of
Directors
present in
the
meeting
Directors
voting in
favour
Directors
voting
against
Directors
remaining
neutral
(1) (2) (3) (4) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17)
Signature Remarks,if
any
Date of the
next
meeting at
which
register was
placed for
signature
Date of
Contract /
Arrangement
Name of the
party with
which
contract is
entered into
Principal terms and conditions Date of
shareholders
approval if
any
Reference
of specific
items - (a)
to (g)
under sub-
section (1)
of section
188
Amount
of
contract
or
arrangem
ent
Whether the
transaction
is at arm's
length basis
Date of
approval
at the
meeting of
the Board
MAKERS LABORATORIES LIMITED
Form MBP - 4
Register of Contracts with Related Party and Contracts and Bodies etc. in which Directors are interested
[Pursuant to section 189(1) and Rule 16(1)]
Details of voting on such resolution
(5)
Name of
the
Interested
Director
Relation
with
Director /
Company /
Nature of
concern or
Interest
to Inv Date Amt
30.06.2019 431LS90012 24/06/2019 230,927
431LS90013 26/06/2019 347,417
431LS90014 26/06/2019 354,399
405LS9000064 18/05/2019 16,281
406LS9000126 07/06/2019 1,478
01.04.2019 08.08.2019
to Inv Date Amt
30.06.2019 113LS900098 25/05/2019 4,248,000
08.08.2019
Inv Date Amt
DA-05 10/06/2019 (53,985.00)
P. M. Kathariya Dipti Shah Nilesh JainR.K. P. Verma Saahil Parikh
Income/Expenditure
Ipca
Laboratories
Limited
Ipca
Laboratories
Limited
Entries made are hereby approved
Details of Purchase
A. Contracts or agreements with any Related Party under section 188 or in which any Director is concerned or interested under sub - section (2) of section 184
No. of
Directors
present in
the
meeting
Directors
voting in
favour
Directors
voting
against
Directors
remaining
neutral
(1) (2) (3) (4) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17)
01.07.2019 Yes 06.11.2019to Inv Date Amt
30.09.2019 431SP90032 03.07.2019 814,386
431SP90033 04.07.2019 600,057
431SP90034 07.07.2019 855,625
431SP90035 10.07.2019 981,384
431SP90036 22.07.2019 1,224,691
431SP90037 24.07.2019 438,700
431SP90038 26.07.2019 815,076
431SP90039 29.07.2019 815,689
431SP90040 01.08.2019 607,822
431SP90041 02.08.2019 1,040,581
431SP90042 05.08.2019 59,944
431SP90043 05.08.2019 386,074
431SP90044 07.08.2019 815,384
431SP90045 09.08.2019 610,631
431SP90046 14.08.2019 914,040
431SP90047 17.08.2019 886,302
431SP90048 19.08.2019 817,489
431SP90049 22.08.2019 803,214
431SP90050 27.08.2019 1,840,071
431SP90051 29.08.2019 400,807
431SP90052 30.08.2019 619,845
431SP90053 02.09.2019 74,931
431SP90054 02.09.2019 874,557
431SP90055 04.09.2019 1,001,976
431SP90056 07.09.2019 402,925
431SP90057 12.09.2019 1,636,610
431SP90058 15.09.2019 444,124
431SP90059 18.09.2019 678,590
431SP90060 22.09.2019 812,733
431SP90061 25.09.2019 541,346
431SP90062 26.09.2019 400,558
431SP90063 27.09.2019 702,571
431SP90064 30.09.2019 1,072,192
405LS9000151 02.07.2019 342
405LS9000299 10.09.2019 342
406LS9000255 30.07.2019 7,458
406LS9000427 23.09.2019 14,193
Date of
Contract /
Arrangement
Name of the
party with
which contract
is entered into
Name of
the
Interested
Director
Date of the
next meeting
at which
register was
placed for
signature
Ipca
Laboratories
Limited
MAKERS LABORATORIES LIMITED
Form MBP - 4
Register of Contracts with Related Party and Contracts and Bodies etc. in which Directors are interested[Pursuant to section 189(1) and Rule 16(1)]
Details of voting on such resolution
(5)
Details of Sales
Amount
of
contract
or
arrangem
ent
Date of
shareholders
approval if
any
Relation
with
Director /
Company /
Nature of
concern or
Interest
Whether the
transaction
is at arm's
length basis
Date of
approval
at the
meeting of
the Board
Signature Remarks,if
any
Principal terms and conditions Reference
of specific
items - (a)
to (g) under
sub-section
(1) of
section 188
A. Contracts or agreements with any Related Party under section 188 or in which any Director is concerned or interested under sub - section (2) of section 184
No. of
Directors
present in
the
meeting
Directors
voting in
favour
Directors
voting
against
Directors
remaining
neutral
(1) (2) (3) (4) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17)
Date of
Contract /
Arrangement
Name of the
party with
which contract
is entered into
Name of
the
Interested
Director
Date of the
next meeting
at which
register was
placed for
signature
MAKERS LABORATORIES LIMITED
Form MBP - 4
Register of Contracts with Related Party and Contracts and Bodies etc. in which Directors are interested[Pursuant to section 189(1) and Rule 16(1)]
Details of voting on such resolution
(5)
Amount
of
contract
or
arrangem
ent
Date of
shareholders
approval if
any
Relation
with
Director /
Company /
Nature of
concern or
Interest
Whether the
transaction
is at arm's
length basis
Date of
approval
at the
meeting of
the Board
Signature Remarks,if
any
Principal terms and conditions Reference
of specific
items - (a)
to (g) under
sub-section
(1) of
section 188
01.07.2019 06.11.2019
to Inv Date Amt
30.09.2019 431LS90015 24.07.2019 761,608
431LS90016 26.07.2019 351,187
431LS90018 14.08.2019 267,700
431LS90019 14.08.2019 137,760
431LS90020 16.08.2019 131,040
431LS90021 16.08.2019 591,977
431LS90022 19.08.2019 275,176
431LS90023 07.09.2019 346,138
431LS90024 14.09.2019 471,205
431LS90025 15.09.2019 94,584
01.07.2019 06.11.2019
to Inv Date Amt
30.09.2019 102LS900911 27.08.2019 401,200
102LS900973 09.09.2019 615,842
06.11.2019
Inv Date AmtDA-10 22.07.2019 (68,281.00) DA-15 27.08.2019 (9,723.00)
P. M. Kathariya Dipti Shah Nilesh Jain
Ipca
Laboratories
Limited
Ipca
Laboratories
Limited
R.K. P. Verma Saahil Parikh
Details of Manufacturing Charges
Details of Purchase
Income/Expenditure
Entries made are hereby approved
A. Contracts or agreements with any Related Party under section 188 or in which any Director is concerned or interested under sub - section (2) of section 184
No. of
Directors
present in
the
meeting
Directors
voting in
favour
Directors
voting
against
Directors
remaining
neutral
(1) (2) (3) (4) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17)
01.10.2019 Yes 06.02.2020to Inv Date Amt
31.12.2019 431SP90065 04.10.2019 841,863
431SP90066 09.10.2019 990,011
431SP90067 10.10.2019 779,936
431SP90068 11.10.2019 149,860
431SP90069 11.10.2019 674,420
431SP90070 14.10.2019 735,175
431SP90071 15.10.2019 526,946
431SP90072 18.10.2019 921,632
431SP90073 18.10.2019 708,433
431SP90074 21.10.2019 795,991
431SP90075 24.10.2019 750,186
431SP90076 01.11.2019 1,835,958
431SP90077 02.11.2019 170,688
431SP90078 02.11.2019 912,349
431SP90079 04.11.2019 729,802
431SP90080 07.11.2019 805,182
431SP90081 11.11.2019 885,139
431SP90082 20.11.2019 776,343
431SP90083 25.11.2019 1,173,779
431SP90084 25.11.2019 35,560
431SP90085 01.12.2019 1,234,130
431SP90086 07.12.2019 659,710
431SP90087 09.12.2019 1,132,849
431SP90088 15.12.2019 855,904
431SP90089 22.12.2019 1,116,926
431SP90090 27.12.2019 755,295
405LS900045 18.11.2019 5,219.00
405LS900046 22.11.2019 3,721.00
405LS900053 23.12.2019 1,430.00
406LS9000476 09.10.2019 4,013
406LS9000477 10.10.2019 1,926
Signature Remarks,if
any
Principal terms and conditions
MAKERS LABORATORIES LIMITED
Form MBP - 4
Register of Contracts with Related Party and Contracts and Bodies etc. in which Directors are interested[Pursuant to section 189(1) and Rule 16(1)]
Details of voting on such resolutionDate of
approval
at the
meeting of
the Board
Date of
Contract /
Arrangement
Name of the
party with
which contract
is entered into
Name of
the
Interested
Director
Date of the
next meeting
at which
register was
placed for
signature
Details of SalesIpca
Laboratories
Limited
Reference
of specific
items - (a)
to (g) under
sub-section
(1) of
section 188
(5)
Amount
of
contract
or
arrangem
ent
Date of
shareholders
approval if
any
Relation
with
Director /
Company /
Nature of
concern or
Interest
Whether the
transaction
is at arm's
length basis
A. Contracts or agreements with any Related Party under section 188 or in which any Director is concerned or interested under sub - section (2) of section 184
No. of
Directors
present in
the
meeting
Directors
voting in
favour
Directors
voting
against
Directors
remaining
neutral
(1) (2) (3) (4) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17)
Signature Remarks,if
any
Principal terms and conditions
MAKERS LABORATORIES LIMITED
Form MBP - 4
Register of Contracts with Related Party and Contracts and Bodies etc. in which Directors are interested[Pursuant to section 189(1) and Rule 16(1)]
Details of voting on such resolutionDate of
approval
at the
meeting of
the Board
Date of
Contract /
Arrangement
Name of the
party with
which contract
is entered into
Name of
the
Interested
Director
Date of the
next meeting
at which
register was
placed for
signature
Reference
of specific
items - (a)
to (g) under
sub-section
(1) of
section 188
(5)
Amount
of
contract
or
arrangem
ent
Date of
shareholders
approval if
any
Relation
with
Director /
Company /
Nature of
concern or
Interest
Whether the
transaction
is at arm's
length basis
01.10.2019 Yes 06.02.2020
to Inv Date Amt
31.12.2019 431LS90027 01.10.2019 360,861
431LS90028 12.10.2019 279,779
431LS90029 07.11.2019 339,612
431LS90031 27.12.2019 768,814
01.10.2019 Yes 06.02.2020
to Inv Date Amt
31.12.2019 102LS900911 27.08.2019 401,200
102LS900973 09.09.2019 615,842
113LS900491 25.12.2019 1,221,300
Yes 06.02.2020
Inv Date AmtDA-21 31.10.2019 (5,272.00) DA-22 30.11.2019 (3,102.00) DA-24 19.12.2019 (7,346.00)
P. M. Kathariya Dipti Shah Nilesh Jain
Entries made are hereby approved
R.K. P. Verma Saahil Parikh
Details of Purchase
Income/Expenditure
Details of Manufacturing ChargesIpca
Laboratories
Limited
Ipca
Laboratories
Limited
A. Contracts or agreements with any Related Party under section 188 or in which any Director is concerned or interested under sub - section (2) of section 184
No. of
Directors
present in
the
meeting
Directors
voting in
favour
Directors
voting
against
Directors
remaining
neutral
(1) (2) (3) (4) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17)
01.01.2020 Yes 15.06.2020to Inv Date Amt
31.03.2020 431SP90091 01/01/2020 1,294,007
431SP90092 05/01/2020 1,046,211
431SP90093 11/01/2020 1,214,652
431SP90094 16/01/2020 1,761,813
431SP90095 19/01/2020 691,454
431SP90096 23/01/2020 1,094,840
431SP90097 25/01/2020 689,055
431SP90098 29/01/2020 1,095,797
431SP90099 01/02/2020 781,084
431SP90100 09/02/2020 544,271
431SP90101 09/02/2020 254,034
431SP90102 13/02/2020 1,194,120
431SP90103 14/02/2020 774,771
431SP90104 14/02/2020 101,602
431SP90105 17/02/2020 909,482
431SP90106 23/02/2020 255,167
431SP90107 23/02/2020 815,477
431SP90108 29/02/2020 1,061,693
431SP90109 04/03/2020 624,615
431SP90110 06/03/2020 512,008
431SP90111 06/03/2020 253,749
431SP90112 12/03/2020 626,202
431SP90113 16/03/2020 1,059,518
431SP90114 21/03/2020 888,261
431SP90115 23/03/2020 918,350
431SP90116 26/03/2020 532,691
431SP90117 30/03/2020 551,248.00
431SP90118 31/03/2020 380,558.00
431SP90119 31/03/2020 249,084.00
405LS9000555 06/01/2020 318.00
406LS9000695 16/01/2020 7,781
406LS9000766 13/02/2020 4,271
406LS9000856 27/03/2020 28,736
Reference
of specific
items - (a)
to (g) under
sub-section
(1) of
section 188
(5)
Amount
of
contract
or
arrangem
ent
Date of
shareholders
approval if
any
Relation
with
Director /
Company /
Nature of
concern or
Interest
Whether the
transaction
is at arm's
length basis
Details of SalesIpca
Laboratories
Limited
MAKERS LABORATORIES LIMITED
Form MBP - 4
Register of Contracts with Related Party and Contracts and Bodies etc. in which Directors are interested[Pursuant to section 189(1) and Rule 16(1)]
Details of voting on such resolutionDate of
approval
at the
meeting of
the Board
Date of
Contract /
Arrangement
Name of the
party with
which contract
is entered into
Name of
the
Interested
Director
Date of the
next meeting
at which
register was
placed for
signature
Signature Remarks,if
any
Principal terms and conditions
A. Contracts or agreements with any Related Party under section 188 or in which any Director is concerned or interested under sub - section (2) of section 184
No. of
Directors
present in
the
meeting
Directors
voting in
favour
Directors
voting
against
Directors
remaining
neutral
(1) (2) (3) (4) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17)
Reference
of specific
items - (a)
to (g) under
sub-section
(1) of
section 188
(5)
Amount
of
contract
or
arrangem
ent
Date of
shareholders
approval if
any
Relation
with
Director /
Company /
Nature of
concern or
Interest
Whether the
transaction
is at arm's
length basis
MAKERS LABORATORIES LIMITED
Form MBP - 4
Register of Contracts with Related Party and Contracts and Bodies etc. in which Directors are interested[Pursuant to section 189(1) and Rule 16(1)]
Details of voting on such resolutionDate of
approval
at the
meeting of
the Board
Date of
Contract /
Arrangement
Name of the
party with
which contract
is entered into
Name of
the
Interested
Director
Date of the
next meeting
at which
register was
placed for
signature
Signature Remarks,if
any
Principal terms and conditions
01.01.2020 Yes 15.06.2020
to Inv Date Amt
31.03.2020 431LS90032 01/01/2020 325,685
431LS90036 18/03/2020 1,222,487
01.01.2020 Yes 15.06.2020
to Inv Date Amt
31.03.2020 102LS902144 14/03/2020 1,306,437
113LS900637 17/03/2020 1,628,400
Inv Date Amt
DA-27 31/01/2020 (2347)
DA-33 31/03/2020 (2557)
P. M. Kathariya Dipti Shah Nilesh Jain
Details of Manufacturing ChargesIpca
Laboratories
Limited
Ipca
Laboratories
Limited
Income/Expenditure
R.K. P. Verma Saahil Parikh
Details of Purchase
Entries made are hereby approved
Rate of
interest
Date of
maturity
(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17)
Investment 25.04.08
Mexin Medicaments Pvt
Ltd. 203A, Vastu Prestige
New Link Road, Andheri
(W) , Mumbai 400053 N.A. N.A. Investment
Complied
with Section
186 25.07.2006 N.A. N.A. N.A.
11990 equity
shares of FV
Rs. 100/-
Rs.
11,99,000
Rs.
1,31,89,000 N.A. N.A.
Investment
From year
2006 till year
2011
Ipca Laboratories Limited,
48, Kandivli Industrial
Estate, Kandivali (W),
Mumbai 400067 N.A. N.A. Investment
Complied
with Section
186 25.07.2006 N.A. N.A. N.A.
101480
equity
shares of FV
Rs. 2/-
Rs.
2,02,960
Rs.
1,01,71,516 N.A. N.A.
Investment 20.03.18
Vedanta Ltd. 1st Floor, C
wing, Unit 103, Corporate
Avenue Atul Projects,
Chakala, Andheri (East)
Mumbai N.A. N.A. Investment
Complied
with Section
186 25.07.2006 N.A. N.A. N.A.
25000
equity
shares of FV
Rs. 10/-
Rs.
2,50,000
Rs.
77,37,849.85 N.A. N.A.
For loans Number
and kind of
securities
Nominal
value and
paid up
value
MAKERS LABORATORIES LIMITEDForm MBP - 2
Register of loans, guarantee, security and acquisition made by the company[Pursuant to section186(9) & rule 12(1)]
Nature of
transaction
(whether
loan/
guarantee/
security/
acquisition)
Date of
making
loan/acquisi
tion / giving
guarantee/
providing
security
Name and address of
the person or body
corporate to whom it is
made or given or whose
securities have been
acquired
(Listed/Unlisted
entities)
Amount of
loan/
security/
acquisition
/guarantee
(Rs.)
Time
period
for
which it
is
made/
given
Purpose of
loan/acquisit
ion
/guarantee/
security
For the Financial Year 2019-20
Cost of
acquisition
(in case of
securities
how the
purchased
price was
arrived at)
Date of
selling of
investment
Selling price
(how the price
was arrived at)
Signatures
and
Remarks
% of loan/
acquisition
/exposure
on
guarantee/
security
provided to
the paid up
capital, free
reserves
and
securities
premium
account and
% of free
reserves
and
securities
premium
Date of
passing
Board
resolution
Date of
passing
special
resolution,
if required